Nanjing Hicin Pharmaceutical Co Ltd (300584) — Capital Reinvestment Ratio

Latest as of June 2025: 0.54x

Nanjing Hicin Pharmaceutical Co Ltd (300584) has a Capital Reinvestment Ratio of 0.54x as of June 2025, meaning it reinvests 1% of its operating cash flow (CN¥22.48 Million) in capital expenditures (CN¥12.11 Million). Check Nanjing Hicin Pharmaceutical Co Ltd (300584) tangible net worth to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.54x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥22.48 Million
CNY

Capital Expenditures

CN¥12.11 Million
CNY

Data as of

Jun 2025
Most recent filing

Nanjing Hicin Pharmaceutical Co Ltd Capital Reinvestment Ratio (2012–2025)

This chart tracks Nanjing Hicin Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 13 annual periods. For the full cash flow conversion analysis, see 300584 cash flow conversion.

Annual Capital Reinvestment Ratio for Nanjing Hicin Pharmaceutical Co Ltd (2012–2025)

Year-by-year Capital Reinvestment Ratio for Nanjing Hicin Pharmaceutical Co Ltd from 2012 to 2025. See Nanjing Hicin Pharmaceutical Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 0.80x CN¥78.09 Million CN¥62.64 Million ▼ -38.3%
2024 1.30x CN¥59.96 Million CN¥77.94 Million ▼ -84.2%
2023 8.24x CN¥23.93 Million CN¥197.22 Million ▲ +423.2%
2021 1.58x CN¥59.94 Million CN¥94.41 Million ▼ -3.8%
2020 1.64x CN¥73.39 Million CN¥120.10 Million ▲ +267.1%
2019 0.45x CN¥97.28 Million CN¥43.36 Million ▼ -55.1%
2018 0.99x CN¥77.21 Million CN¥76.67 Million ▼ -30.5%
2017 1.43x CN¥46.56 Million CN¥66.52 Million ▲ +18.2%
2016 1.21x CN¥37.74 Million CN¥45.63 Million ▲ +127.6%
2015 0.53x CN¥53.90 Million CN¥28.63 Million ▼ -55.6%
2014 1.20x CN¥24.29 Million CN¥29.07 Million ▲ +29.9%
2013 0.92x CN¥45.16 Million CN¥41.61 Million ▼ -47.5%
2012 1.75x CN¥38.77 Million CN¥68.03 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow